Yes, this stock is trading on future success. The chief complaint in scientific circles is that cannabis, in raw form, lacks standardization. CBIS's ability to provide a standardized blend of whole cannabis, in a patented delivery method, targeting specific diseases could be worth hundreds of millions of dollars.
Okay, so that's the principle reason there are many longs. Not just a hope dream, but a real cure or easement for hard to treat diseases. The longs take the ups and the downs, while some flip for more shares.
Here is the current numbers before Friday's new numbers.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.